{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-055061","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2021-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.235275+00:00","generated_at":"2026-06-28T11:20:22.607268+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Precision BioSciences appoints Sam Wadsworth and Shari Lisa Piré to Board of Directors","bullets":["Sam Wadsworth, Ph.D. (CSO, Ultragenyx Gene Therapy) appointed Class II director; brings 30 years gene therapy experience.","Shari Lisa Piré, J.D. (Chief Legal & Sustainability Officer, Plume Design) appointed Class III director; over 20 years legal/corporate experience.","New directors eligible for $40K annual cash retainer, $350K initial equity award vesting over 3 years, plus annual option awards.","Company states it aims to advance three INDs/CTAs over next three years and continue allogeneic CAR T programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-055061","json":"https://secwatch.observer/filing/0001564590-21-055061.json","markdown":"https://secwatch.observer/filing/0001564590-21-055061.md","text":"https://secwatch.observer/filing/0001564590-21-055061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/0001564590-21-055061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/dtil-8k_20211106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T11:20:22.607268+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a47eb7176","claim":"Shari Lisa Piré was appointed as Class III director at PRECISION BIOSCIENCES INC.","evidence_excerpt":"Shari Lisa Piré to serve as a Class III director on the Company’s Board and as a member of the Nominating and Corporate Governance Committee of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/0001564590-21-055061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"},{"claim_id":"5ad809c607","claim":"Samuel Wadsworth was appointed as Class II director at PRECISION BIOSCIENCES INC.","evidence_excerpt":"Samuel Wadsworth, Ph.D. to serve as a Class II director on the Company’s Board and as a member of the Science and Technology Committee of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/0001564590-21-055061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}